Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
5.34
+0.07 (1.33%)
At close: Mar 23, 2026, 4:00 PM EDT
5.34
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:10 PM EDT
Harvard Bioscience Employees
As of December 31, 2024, Harvard Bioscience had 355 total employees, including 330 full-time and 25 part-time employees. The number of employees decreased by 61 or -14.66% compared to the previous year.
Employees
355
Change (1Y)
-61
Growth (1Y)
-14.66%
Revenue / Employee
$243,803
Profits / Employee
-$159,718
Market Cap
238.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 355 | -61 | -14.66% | 330 | 25 |
| Dec 31, 2023 | 416 | -39 | -8.57% | 391 | 25 |
| Dec 31, 2022 | 455 | -39 | -7.89% | 436 | 19 |
| Dec 31, 2021 | 494 | 35 | 7.63% | 475 | 19 |
| Dec 31, 2020 | 459 | -46 | -9.11% | 428 | 31 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 1,850 |
| AngioDynamics | 675 |
| OraSure Technologies | 500 |
| Nyxoah | 184 |
| Pro-Dex | 181 |
| Anteris Technologies Global | 174 |
| Utah Medical Products | 167 |
| Sanara MedTech | 141 |
HBIO News
- 11 days ago - Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 17 days ago - Harvard Bioscience Announces Reverse Stock Split - GlobeNewsWire
- 20 days ago - Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum - GlobeNewsWire
- 25 days ago - Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - GlobeNewsWire
- 5 weeks ago - Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas - GlobeNewsWire
- 7 weeks ago - Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth - GlobeNewsWire
- 3 months ago - Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package - GlobeNewsWire